BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18367522)

  • 1. Mutations affecting the MA portion of the v-Abl protein reveal a conserved role of Gag in Abelson murine leukemia virus (MLV) and Moloney MLV.
    Yi CR; Rosenberg N
    J Virol; 2008 Jun; 82(11):5307-15. PubMed ID: 18367522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gag influences transformation by Abelson murine leukemia virus and suppresses nuclear localization of the v-Abl protein.
    Yi CR; Rosenberg N
    J Virol; 2007 Sep; 81(17):9461-8. PubMed ID: 17596313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus.
    Warren D; Griffin DS; Mainville C; Rosenberg N
    J Virol; 2003 Apr; 77(8):4617-25. PubMed ID: 12663768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The carboxyl terminus of v-Abl protein can augment SH2 domain function.
    Warren D; Heilpern AJ; Berg K; Rosenberg N
    J Virol; 2000 May; 74(10):4495-504. PubMed ID: 10775585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.
    Mainville CA; Parmar K; Unnikrishnan I; Gong L; Raffel GD; Rosenberg N
    J Virol; 2001 Feb; 75(4):1816-23. PubMed ID: 11160680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.
    Usami Y; Popov S; Göttlinger HG
    J Virol; 2014 Mar; 88(6):3443-54. PubMed ID: 24403584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of p53 complements defects in Abelson murine leukemia virus signaling.
    Unnikrishnan I; Rosenberg N
    J Virol; 2003 Jun; 77(11):6208-15. PubMed ID: 12743277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation Requirement of Murine Leukemia Virus p12.
    Brzezinski JD; Felkner R; Modi A; Liu M; Roth MJ
    J Virol; 2016 Dec; 90(24):11208-11219. PubMed ID: 27707931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras complements the carboxyl terminus of v-Abl protein in lymphoid transformation.
    Parmar K; Rosenberg N
    J Virol; 1996 Feb; 70(2):1009-15. PubMed ID: 8551558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.
    Mysliwiec T; Perego R; Kruh GD
    Oncogene; 1996 Feb; 12(3):631-40. PubMed ID: 8637720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of the Chromatin-Tethering Domain of Murine Leukemia Virus p12.
    Brzezinski JD; Modi A; Liu M; Roth MJ
    J Virol; 2016 Dec; 90(24):11197-11207. PubMed ID: 27707926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a murine leukemia virus Gag-Escherichia coli RNase HI fusion polyprotein significantly inhibits virus spread.
    VanBrocklin M; Ferris AL; Hughes SH; Federspiel MJ
    J Virol; 1997 Apr; 71(4):3312-8. PubMed ID: 9060701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SH2-containing inositol 5'-phosphatase inhibits transformation of Abelson murine leukemia virus.
    Fessler SP; Rosenberg N; Baughn LB
    J Virol; 2011 Sep; 85(17):9239-42. PubMed ID: 21697469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.
    Lee SK; Nagashima K; Hu WS
    J Virol; 2005 Apr; 79(7):4159-69. PubMed ID: 15767417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro.
    Watanabe SM; Rosenberg NE; Witte ON
    J Virol; 1984 Sep; 51(3):620-7. PubMed ID: 6088787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p12 domain is unstructured in a murine leukemia virus p12-CA(N) Gag construct.
    Kyere SK; Joseph PR; Summers MF
    PLoS One; 2008 Apr; 3(4):e1902. PubMed ID: 18382677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defects in virion production caused by mutations affecting the C-terminal portion of the Moloney murine leukemia virus capsid protein.
    Wang MQ; Goff SP
    J Virol; 2003 Mar; 77(5):3339-44. PubMed ID: 12584360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the Shc/Grb2 complex during abelson virus transformation affects proliferation, but not apoptosis.
    Baughn LB; Rosenberg N
    J Virol; 2005 Feb; 79(4):2325-34. PubMed ID: 15681433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the moloney murine leukemia virus RNase H domain.
    Lim D; Gregorio GG; Bingman C; Martinez-Hackert E; Hendrickson WA; Goff SP
    J Virol; 2006 Sep; 80(17):8379-89. PubMed ID: 16912289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo association of v-Abl with Shc mediated by a non-phosphotyrosine-dependent SH2 interaction.
    Raffel GD; Parmar K; Rosenberg N
    J Biol Chem; 1996 Mar; 271(9):4640-5. PubMed ID: 8617726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.